Head-to-head comparison of the three most commonly used preoperative models for prediction of biochemical recurrence after radical prostatectomy
- PMID: 20018437
- DOI: 10.1016/j.eururo.2009.12.003
Head-to-head comparison of the three most commonly used preoperative models for prediction of biochemical recurrence after radical prostatectomy
Abstract
Background: Several models can predict the rate of biochemical recurrence (BCR) after radical prostatectomy (RP).
Objective: We tested the three most commonly used models-the D'Amico risk stratification scheme, the Cancer of the Prostate Risk Assessment (CAPRA) score, and the Stephenson nomogram-in a European cohort of RP patients.
Design, setting, and participants: We relied on preoperative characteristics and prostate-specific antigen follow-up data of 1976 patients, as required by the three tested models. All patients were treated with an open RP between 1992 and 2006.
Measurements: Analyses included tests of accuracy (Harrell's concordance index) and calibration between predicted and observed BCR rates at 3 yr and 5 yr after RP. Additionally, we relied on decision curve analyses to compare the three models directly in a head-to-head fashion.
Results and limitations: The median follow-up of censored patients was 32 mo. BCR-free rates at 3 yr and 5 yr after RP were 80.2% and 72.6%, respectively. The concordance index for 3-yr BCR predictions was 70.4%, 74.3%, and 75.2% for the D'Amico, CAPRA, and Stephenson models, respectively, versus 67.4%, 72.9%, and 73.5% for 5-yr BCR predictions. Calibration results supported the use of either the CAPRA or Stephenson models. Decision curve analyses indicated a small benefit for the CAPRA score relative to the Stephenson nomogram. Our findings apply to German patients treated with RP at a high-volume tertiary care centre. Consequently, the rank order reported in this paper may not be the same in North American or other European cohorts.
Conclusions: Different methods yield different results, and it may be difficult to reconcile concordance index, calibration, and decision curve analysis findings. Our data suggest that the CAPRA score outperforms the other models when decision curve analysis and calibration were used as benchmarks. Conversely, the Stephenson nomogram outperformed the other models when concordance index was used as a metric.
Crown Copyright © 2009. Published by Elsevier B.V. All rights reserved.
Comment in
-
Prediction models in urology: are they any good, and how would we know anyway?Eur Urol. 2010 Apr;57(4):571-3; discussion 574. doi: 10.1016/j.eururo.2009.12.026. Epub 2009 Dec 29. Eur Urol. 2010. PMID: 20071072 Free PMC article. No abstract available.
-
Comparing prediction tools.Eur Urol. 2010 Apr;57(4):569-70; discussion 574. doi: 10.1016/j.eururo.2010.01.006. Epub 2010 Jan 14. Eur Urol. 2010. PMID: 20080334 No abstract available.
Similar articles
-
Comparing prediction tools.Eur Urol. 2010 Apr;57(4):569-70; discussion 574. doi: 10.1016/j.eururo.2010.01.006. Epub 2010 Jan 14. Eur Urol. 2010. PMID: 20080334 No abstract available.
-
Nomogram predicting the probability of early recurrence after radical prostatectomy for prostate cancer.J Urol. 2009 Feb;181(2):601-7; discussion 607-8. doi: 10.1016/j.juro.2008.10.033. Epub 2008 Dec 13. J Urol. 2009. PMID: 19084864
-
Length of positive surgical margin after radical prostatectomy as a predictor of biochemical recurrence.J Urol. 2009 Jul;182(1):139-44. doi: 10.1016/j.juro.2009.02.139. Epub 2009 May 17. J Urol. 2009. PMID: 19450829
-
[Indications for and results of radical prostatectomy].Urologe A. 2003 Sep;42(9):1203-11. doi: 10.1007/s00120-003-0429-x. Urologe A. 2003. PMID: 14504753 Review. German.
-
[Predictive models for biochemical recurrence of prostate cancer after local treatment. Nomograms].Arch Esp Urol. 2012 Jan-Feb;65(1):39-50. Arch Esp Urol. 2012. PMID: 22318176 Review. Spanish.
Cited by
-
Preoperative sex steroids are significant predictors of early biochemical recurrence after radical prostatectomy.World J Urol. 2013 Apr;31(2):275-80. doi: 10.1007/s00345-012-0856-7. Epub 2012 Mar 24. World J Urol. 2013. PMID: 22441310
-
Treatment of localized prostate cancer: when is active surveillance appropriate?Nat Rev Clin Oncol. 2010 Jul;7(7):394-400. doi: 10.1038/nrclinonc.2010.63. Epub 2010 May 4. Nat Rev Clin Oncol. 2010. PMID: 20440282 Review.
-
Prediction of disease progression indicators in prostate cancer patients receiving HDR-brachytherapy using Raman spectroscopy and semi-supervised learning: a pilot study.Sci Rep. 2022 Sep 6;12(1):15104. doi: 10.1038/s41598-022-19446-4. Sci Rep. 2022. PMID: 36068275 Free PMC article.
-
MRI-derived tumor volume as a predictor of biochemical recurrence and adverse pathology in patients after radical prostatectomy: a propensity score matching study.J Cancer Res Clin Oncol. 2023 Sep;149(11):8853-8861. doi: 10.1007/s00432-023-04825-9. Epub 2023 May 6. J Cancer Res Clin Oncol. 2023. PMID: 37148292 Free PMC article.
-
Biopsy-free AI-aided precision MRI assessment in prediction of prostate cancer biochemical recurrence.Br J Cancer. 2023 Nov;129(10):1625-1633. doi: 10.1038/s41416-023-02441-5. Epub 2023 Sep 27. Br J Cancer. 2023. PMID: 37758837 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical